StockNews.AI
DOC
StockNews.AI
1 min

Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2025

1. Healthpeak Properties declared a monthly dividend of $0.10167 per share. 2. Annualized dividend amount totals $1.22 per share of common stock. 3. Dividends payable through October to December 2025. 4. Healthpeak is a top real estate investment trust in healthcare.

7m saved
Insight
Article

FAQ

Why Bullish?

Dividend declarations often signal company stability and financial health, potentially boosting investor confidence and stock price.

How important is it?

The dividend reflects Healthpeak's financial stability, which is crucial for attracting dividend-focused investors, thus impacting future pricing.

Why Short Term?

Investors may react positively to the dividend announcement, thus likely impacting stock price in the near term.

Related Companies

Healthpeak Properties, Inc. (NYSE:DOC), a leading owner, operator, and developer of real estate for healthcare discovery and delivery, announced that on October 6, 2025, its Board of Directors declared a monthly common stock cash dividend of $0.10167 per share for the fourth quarter of 2025, payable on the payment dates set forth in the table below to stockholders of record as of the close of business on the corresponding record date in the table below. The monthly dividend reflects an annualized dividend amount of $1.22 per share of common stock.

Record Date

Payment Date

Amount

October 17, 2025

October 30, 2025

$0.10167 per common share

November 14, 2025

November 26, 2025

$0.10167 per common share

December 19, 2025

December 30, 2025

$0.10167 per common share

ABOUT HEALTHPEAK PROPERTIES

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. For more information regarding Healthpeak, visit www.healthpeak.com.

Andrew Johns, CFA

Senior Vice President – Finance and Investor Relations

720-428-5050

Related News